Clinical Trials

Title: A Humanitarian Device Exemption Use Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia

Department: Oncology

Diagnosis: Gastrointestinal - Liver

Principal Investigator: Joseph A Ronsivalle, DO

Sponsors: BTG

Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn's Disease

Department: Gastroenterology

Diagnosis: Gastrointestinal - Crohn's

Principal Investigator: Michael J Georgetson, MD

• Matthew Lincoln, DO
• Thomas J McDonald, MD
• Ukorn Srivatana, MD
• Debra L Moore, CRNP, MSN, FNP-BC

Sponsors: BMS

Title: A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Department: Oncology

Diagnosis: Breast

Principal Investigator: Thomas J Gergel, MD

• Melissa Cantellops, FNP
• Omar Yumen, MD
• M. Firdos Ziauddin, MD, FACS

Sponsors: ALLIANCE

Title: A011502, A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

Department: Oncology

Diagnosis: Breast

Principal Investigator: Philip A Lowry, MD

• Cynthia M Perry-Keaty, FNP, AOCNP
• Catherine A Morelli, PA-C
• Kelby R O'Neil, PA-C
• Jennifer Schecter, FNP-C, AOCNP

Sponsors: ALLIANCE

Title: A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

Department: Oncology

Diagnosis: Gastrointestinal - Colon-Rectal

Principal Investigator: Joyson Poulose, MD

• Jennifer Schecter, FNP-C, AOCNP
• Cynthia M Perry-Keaty, FNP, AOCNP
• Catherine A Morelli, PA-C
• Kelby R O'Neil, PA-C
• Philip A Lowry, MD
• Vineela Kasireddy, MD

Sponsors: ALLIANCE

Title: A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer (SOLARIS)

Department: Oncology

Diagnosis: Gastrointestinal - Colon-Rectal

Principal Investigator: Philip A Lowry, MD

• Jennifer Schecter, FNP-C, AOCNP
• Kelby R O'Neil, PA-C
• Catherine A Morelli, PA-C
• Joyson Poulose, MD
• Vineela Kasireddy, MD
• Cynthia M Perry-Keaty, FNP, AOCNP

Sponsors: ALLIANCE

Title: A031704: PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated Renal Cell Cancer [PDIGREE]

Department: Oncology

Diagnosis: Genito-urinary - Renal

Principal Investigator: Philip A Lowry, MD

• Joyson Poulose, MD
• Kelby R O'Neil, PA-C
• Vineela Kasireddy, MD
• Cynthia M Perry-Keaty, FNP, AOCNP
• Catherine A Morelli, PA-C
• Jennifer Schecter, FNP-C, AOCNP

Sponsors: ALLIANCE

Title: A071801: Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS (FSRS) for Resected Metastatic Brain Disease

Department: Oncology

Diagnosis: Brain

Principal Investigator: Thomas J Gergel, MD

• Omar Yumen, MD

Sponsors: ALLIANCE

Title: A221505, Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

Department: Oncology

Diagnosis: Breast

Principal Investigator: Thomas J Gergel, MD

• Omar Yumen, MD

Sponsors: ALLIANCE

Title: A221602: Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial

Department: Oncology

Diagnosis: Oncology - General

Principal Investigator: Philip A Lowry, MD

• Joyson Poulose, MD
• Vineela Kasireddy, MD
• Jennifer Schecter, FNP-C, AOCNP
• Cynthia M Perry-Keaty, FNP, AOCNP
• Kelby R O'Neil, PA-C
• Catherine A Morelli, PA-C

Sponsors: ALLIANCE